Invention Grant
- Patent Title: HCV genotype 6 replicons
- Patent Title (中): HCV基因型6个复制子
-
Application No.: US14073488Application Date: 2013-11-06
-
Publication No.: US09353423B2Publication Date: 2016-05-31
- Inventor: Guofeng Cheng , William E. Delaney, IV , Betty Peng , Mei Yu
- Applicant: Gilead Sciences, Inc.
- Applicant Address: US CA Foster City
- Assignee: Gilead Sciences, Inc.
- Current Assignee: Gilead Sciences, Inc.
- Current Assignee Address: US CA Foster City
- Agent Yu-Ming Dammann
- Main IPC: C12Q1/70
- IPC: C12Q1/70 ; C07K16/00 ; C07K14/005 ; C07K16/10 ; C12N7/00
Abstract:
Replicons of genotype 6 hepatitis C virus (HCV) are provided. These replicons contain adaptive mutations giving rise to the HCV's capability to replicate in vitro. Methods of preparing genotype 6 replicons and methods of using these replicons to screen antiviral agents are also provided.
Public/Granted literature
- US20140134604A1 HCV GENOTYPE 6 REPLICONS Public/Granted day:2014-05-15
Information query
